Fluconazole Susceptibilities of Bloodstream Candidasp. Isolates as Determined by National Committee for Clinical Laboratory Standards Method M27-A and Two Other Methods
暂无分享,去创建一个
J. Pemán | E. Cantón | Á. Viudes | M. Gobernado | A. Carrillo-Muñoz | A. Orero | P. Úbeda
[1] E. Anaissie,et al. Optimizing the Correlation between Results of Testing In Vitro and Therapeutic Outcome In Vivo for Fluconazole by Testing Critical Isolates in a Murine Model of Invasive Candidiasis , 1998, Antimicrobial Agents and Chemotherapy.
[2] J. Billé,et al. Evaluation of the susceptibility of pathogenic Candida species to fluconazole. Fluconazole Global Susceptibility Study Group. , 1997, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.
[3] S. Unal,et al. In vitro activity of a new echinocandin, LY303366, compared with those of amphotericin B and fluconazole against clinical yeast isolates , 1997, Antimicrobial agents and chemotherapy.
[4] H. Hayakawa,et al. T-8581, a new orally and parenterally active triazole antifungal agent: in vitro and in vivo evaluations , 1997, Antimicrobial agents and chemotherapy.
[5] A. Barry,et al. Fluconazole disk diffusion procedure for determining susceptibility of Candida species , 1996, Journal of clinical microbiology.
[6] G. Gilbert,et al. Antifungal susceptibility testing using the E test: comparison with the broth macrodilution technique. , 1996, The Journal of antimicrobial chemotherapy.
[7] J. Martínez-Suárez,et al. Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro testing of fluconazole-resistant and -susceptible isolates of Candida albicans , 1995, Journal of clinical microbiology.
[8] W. Jarvis. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] M. Larocco,et al. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period , 1994, Antimicrobial Agents and Chemotherapy.
[10] J. Martínez-Suárez,et al. Improved medium for fluconazole susceptibility testing of Candida albicans , 1994, Antimicrobial Agents and Chemotherapy.
[11] A. Bjørneklett,et al. Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance. The Norwegian Yeast Study Group , 1993, Antimicrobial Agents and Chemotherapy.
[12] F. Mandelli,et al. Fungemia in Patients with Leukemia , 1993, The American journal of the medical sciences.
[13] T. Walsh,et al. Standardized susceptibility testing of fluconazole: an international collaborative study , 1992, Antimicrobial Agents and Chemotherapy.
[14] S. Clissold,et al. Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. , 1990, Drugs.
[15] J. Galgiani,et al. Collaborative investigation of variables in susceptibility testing of yeasts , 1990, Antimicrobial Agents and Chemotherapy.
[16] R. Payne,et al. Yeasts: Characteristics and Identification , 1983 .
[17] E. Bruck,et al. National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.